Mirum Pharmaceuticals, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Mirum Pharmaceuticals, Inc. (MIRM), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are MIRM insiders buying or selling?
Mirum Pharmaceuticals, Inc. insiders reported 43 open-market buys ($127.3M) and 100 sells ($61.6M) across 143 Form 4 filings — a net buying position of $65.7M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 8, 2026)
Insider sentiment
Net buyingNet insider flow of $65.7M in net buying.
Recent MIRM insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | Sale | 20.0K | $122.27 | $2.4M |
| Jul 8, 2026 | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Sale | 5.0K | $122.25 | $611.3K |
| Jul 2, 2026 | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale | 2.7K | $120.00 | $326.5K |
| Jun 18, 2026 | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale | 2.6K | $101.95 | $264.5K |
| Jun 10, 2026 | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Sale | 5.0K | $93.82 | $469.1K |
| Jun 2, 2026 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | Sale | 30.0K | $95.84 | $2.9M |
| Jun 2, 2026 | Saira Ramasastry | Director | Sale | 4.0K | $100.00 | $397.7K |
| May 19, 2026 | Saira Ramasastry | Director | Sale | 2.0K | $109.47 | $218.9K |
| Apr 17, 2026 | Saira Ramasastry | Director | Sale | 2.0K | $96.90 | $193.8K |
| Mar 17, 2026 | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Sale | 7.3K | $91.98 | $670.2K |
| Mar 17, 2026 | Joanne Quan | CHIEF MEDICAL OFFICER | Sale | 7.3K | $91.98 | $670.2K |
| Mar 17, 2026 | Saira Ramasastry | Director | Sale | 2.0K | $90.76 | $181.5K |
| Mar 17, 2026 | Peter Radovich | PRESIDENT AND COO | Sale | 16.5K | $91.98 | $1.5M |
| Mar 17, 2026 | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale | 4.7K | $91.98 | $435.2K |
| Mar 17, 2026 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | Sale | 41.0K | $91.98 | $3.8M |
| Feb 17, 2026 | Saira Ramasastry | Director | Sale | 2.0K | $102.09 | $204.2K |
| Feb 4, 2026 | Peter Radovich | PRESIDENT AND COO | Sale | 2.6K | $103.30 | $271.8K |
| Feb 4, 2026 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | Sale | 9.1K | $103.30 | $940.9K |
| Feb 4, 2026 | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale | 968 | $103.30 | $100.0K |
| Jan 27, 2026 | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | Sale | 1.1K | $96.19 | $101.3K |
| Jan 27, 2026 | Peter Radovich | PRESIDENT AND COO | Sale | 3.1K | $96.19 | $302.3K |
| Jan 27, 2026 | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale | 842 | $96.19 | $81.0K |
| Jan 27, 2026 | Christopher Peetz | CHIEF EXECUTIVE OFFICER | Sale | 6.8K | $96.19 | $657.1K |
| Jan 27, 2026 | Patrick J Heron | Director | Purchase | 131.4K | $68.48 | $9.0M |
| Jan 23, 2026 | Jolanda Howe | SVP, GLOBAL CONTROLLER | Sale | 926 | $93.33 | $86.4K |
Showing the 25 most recent of 143 Form 4 filings for Mirum Pharmaceuticals, Inc..
Most active MIRM insiders
- Christopher Peetz21 filings
- Jolanda Howe20 filings
- Peter Radovich15 filings
- Patrick J Heron12 filings
- Saira Ramasastry11 filings
Ask anything about MIRM insider activity
Use Trabud's AI agent to query Mirum Pharmaceuticals, Inc.'s Form 4 history in plain English — "Show me MIRM CEO purchases this year" or compare it against any other ticker.
Open the AI agentMIRM insider trading FAQ
Are Mirum Pharmaceuticals, Inc. insiders buying or selling?
Across 143 SEC Form 4 filings, Mirum Pharmaceuticals, Inc. (MIRM) insiders reported 43 open-market purchases totaling $127.3M and 100 sales totaling $61.6M. That is a net buying position of $65.7M.
How many insiders trade MIRM stock?
31 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Mirum Pharmaceuticals, Inc.. The most recent filing was accepted on Jul 8, 2026.
Where does Trabud get MIRM insider trading data?
All MIRM insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.